Abstract
Epithelial ovarian cancer is still the most lethal gynecological malignancy, with a recurrence rate of 70% in advanced cases. Adi and compound sophora flavescens have shown potential as antitumor injections for several cancers. Here, we present a case of advanced epithelial ovarian cancer treated with Adi combined with compound sophora flavescens injection for prevention of recurrence and metastasis. The current survival period of the patient has reached 122 months. Surprisingly, a durable tumor control has occurred. Although the use of Aidi in combination with compound matrine injection as a treatment for ovarian cancer is not fully understood, it has demonstrated satisfactory clinical efficacy and no significant adverse reactions.
Keyword: Advanced epithelial ovarian cancer; Recurrence and metastasis; Aidi injection; Compound Sophora flavescens injection